Santonocito, D.; Barbagallo, I.; Distefano, A.; Sferrazzo, G.; Vivero-Lopez, M.; Sarpietro, M.G.; Puglia, C.
Nanostructured Lipid Carriers Aimed to the Ocular Delivery of Mangiferin: In Vitro Evidence. Pharmaceutics 2023, 15, 951.
https://doi.org/10.3390/pharmaceutics15030951
AMA Style
Santonocito D, Barbagallo I, Distefano A, Sferrazzo G, Vivero-Lopez M, Sarpietro MG, Puglia C.
Nanostructured Lipid Carriers Aimed to the Ocular Delivery of Mangiferin: In Vitro Evidence. Pharmaceutics. 2023; 15(3):951.
https://doi.org/10.3390/pharmaceutics15030951
Chicago/Turabian Style
Santonocito, Debora, Ignazio Barbagallo, Alfio Distefano, Giuseppe Sferrazzo, Maria Vivero-Lopez, Maria Grazia Sarpietro, and Carmelo Puglia.
2023. "Nanostructured Lipid Carriers Aimed to the Ocular Delivery of Mangiferin: In Vitro Evidence" Pharmaceutics 15, no. 3: 951.
https://doi.org/10.3390/pharmaceutics15030951
APA Style
Santonocito, D., Barbagallo, I., Distefano, A., Sferrazzo, G., Vivero-Lopez, M., Sarpietro, M. G., & Puglia, C.
(2023). Nanostructured Lipid Carriers Aimed to the Ocular Delivery of Mangiferin: In Vitro Evidence. Pharmaceutics, 15(3), 951.
https://doi.org/10.3390/pharmaceutics15030951
